Bickerstaff George
SEC Form 4 insider trading activity
Bickerstaff George has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Aug 6, 2026.
On the most recent filing, Bickerstaff George is listed as Director at CareDx, Inc. Inside the rolling window, Bickerstaff George reported no open-market purchases and 1 open-market sale totaling $926K in CDNA.
Companies traded
Other insiders at CDNA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$926K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Bickerstaff George made?
Bickerstaff George has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.
Which companies does Bickerstaff George trade?
Bickerstaff George has filed SEC Form 4 disclosures for 1 company, including CDNA.
When was Bickerstaff George's most recent SEC Form 4 filing?
Bickerstaff George's most recent SEC Form 4 filing on Tracefour is dated Aug 6, 2026.
What is Bickerstaff George's total buy and sell value in the current window?
Inside the rolling retention window, Bickerstaff George bought $0 and sold $926K based on SEC Form 4 filings.
What was Bickerstaff George's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 20,000 CDNA shares on 2026-08-05, worth $926K, per SEC Form 4 filings.